Xencor (United States)
Xencor is expanding the therapeutic boundaries of antibody drugs. Powered by its XmAb® protein engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat patients with cancer and other serious diseases. More than 20 programs are in clinical testing, and many more are in preclinical development.
Basic Information
- Category: business
- Website: https://www.xencor.com/
Documented Facts
- Phone: (626) 305-5900 (No linked source recorded for this statement.)
- Email: info@xencor.com (No linked source recorded for this statement.)
Evidence and Sources
- Xencor (United States) — Official Site (official)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Xencor (United States).
- Canonical profile: https://brandsource.ai/brands/xencor-united-states
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/xencor-united-states/json-ld
- Citation profile API: https://brandsource.ai/api/brands/xencor-united-states/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Xencor is expanding the therapeutic boundaries of antibody drugs. Powered by its XmAb® protein engineering platform, Xencor is developing a broad pipeline of drug candidates that are optimized to treat patients with cancer and other serious diseases. More than 20 programs are in clinical testing, and many more are in preclinical development.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.